Injectable dosage form of flupirtine
AssigneeAwd.Pharma GmbH & Co. KG
InventorsChristoph Martin Hoock, Asal Qadan, Bernd Terhaag, Rudy Thoma
Life of this patent
Estimating the term…
Loading patent…
AssigneeAwd.Pharma GmbH & Co. KG
InventorsChristoph Martin Hoock, Asal Qadan, Bernd Terhaag, Rudy Thoma
Estimating the term…
The present invention relates to a flupirtine-containing lyophilisate, the use of this lyophilisate to produce a pharmaceutical composition to be parenterally applied, a procedure to produce a flupirtine-containing pharmaceutical composition to be parenterally applied, and a procedure to produce the flupirtine-containing lyophilisate as well as the flupirtine-containing pharmaceutical composition produced using the lyophilisate. For this purpose a lyophilisate is provided which contains the active ingredient flupirtine in the form of a physiologically tolerated salt, which has a solubility in water of at least 2.5 mg/ml, preferably at least 5 mg/ml, especially preferably at least 10 mg/ml, and contains one or more cyclodextrins or cyclodextrin derivatives, and which may be used to produce a pharmaceutical composition to be parenterally applied.
A lyophilisate, which contains a physiologically tolerated flupirtine sail with a solubility in water of at least 2.5 mg/ml as an active ingredient and furhter contains at least one cyclodextrin and/or cyclodextrin derivative.
The pharmaceutical composition according to claim 9, wherein the pharmaceutical composition to be parenterally applied is an injection solution and/or infusion solution.
Dependencies are inferred from the claim text.